Tibet AIM Pharm. Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 158.204 million compared to CNY 96.087 million a year ago. Operating income was CNY 6.778 million compared to CNY 2.430 million a year ago. Net income was CNY 5.259 million compared to CNY 5.968 million a year ago. Basic earnings per share from continuing operations was CNY 0.03 compared to CNY 0.03 a year ago.